Oncotelic Therapeutics, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Oncotelic Therapeutics, Inc. (OTLC) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $263.44 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $263.44M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $262.21M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $261.73M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $8.08M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $263.44M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $262.21M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $261.73M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $8.08M 10-Q · filed 2025-11-17 | |
| 2025-06-30 | $7.39M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $7.18M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $7.48M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $8.13M 10-Q · filed 2025-11-17 | |
| 2024-06-30 | $11.50M 10-Q · filed 2025-11-17 | |
| 2024-03-31 | $11.25M 10-Q · filed 2025-11-17 | $11.25M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $11.61M 10-K · filed 2026-04-15 | |
| 2023-09-30 | $12.09M 10-Q · filed 2024-11-19 | |
| 2023-06-30 | $11.93M 10-Q · filed 2024-11-19 | $11.93M 10-Q · filed 2023-08-18 |
| 2023-03-31 | $18.45M 10-Q · filed 2024-11-19 | |
| 2022-12-31 | $19.19M 10-K · filed 2025-04-15 | |
| 2022-09-30 | $24.03M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $24.28M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $6.32M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $8.16M 10-K · filed 2024-04-12 | |
| 2021-09-30 | $8.39M 10-Q · filed 2022-11-18 | |
| 2021-06-30 | $9.59M 10-Q · filed 2022-11-18 | |
| 2021-03-31 | $10.96M 10-Q · filed 2022-11-18 | |
| 2020-12-31 | $12.48M 10-K/A · filed 2023-04-20 | |
| 2020-09-30 | $15.86M 10-Q · filed 2021-11-22 | |
| 2020-06-30 | $15.80M 10-Q · filed 2021-11-22 | |
| 2020-03-31 | $15.11M 10-Q · filed 2021-11-22 | |
| 2019-12-31 | $16.90M 10-K · filed 2022-04-15 | |
| 2019-09-30 | $4.80M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $5.62M 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $2.50M 10-Q · filed 2020-11-16 | |
| 2018-12-31 | $2.46M 10-K · filed 2021-04-15 |